Published in Australas Ann Med on November 01, 1966
Genetics and gastroenterology. Gut (1971) 0.81
ABO blood groups and gastrointestinal function. Gut (1970) 0.80
Editorial: Genetics of duodenal ulcer. Br Med J (1975) 0.75
A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology (1994) 3.23
The use of equilibrium-density-gradient methods for the preparation and characterization of blood-group-specific glycoproteins. Biochem J (1970) 2.98
Inheritance of malignant hyperpyrexia. Lancet (1972) 2.33
Biochemical basis of malignant hyperpyrexia. Br Med J (1974) 2.01
Biochemical changes in malignant hyperpyrexia. Lancet (1970) 1.90
Myopathy and malignant hyperpyrexia. Lancet (1970) 1.87
Dantrolene and "ecstasy". Med J Aust (1997) 1.87
Arrhythmias and late sudden death after myocardial infarction. Lancet (1968) 1.68
Identification of susceptibility to malignant hyperpyrexia. Br Med J (1974) 1.66
Sources of calcium for contraction of guinea-pig isolated tracheal smooth muscle. Clin Exp Pharmacol Physiol (1981) 1.57
Procaine in malignant hyperpyrexia. Br Med J (1972) 1.49
Malignant hyperpyrexia and sudden infant death. Lancet (1982) 1.36
Heat stroke and malignant hyperpyrexia. Med J Aust (1982) 1.36
Rhabdomyolysis and malignant hyperpyrexia. Br Med J (Clin Res Ed) (1984) 1.22
Central-core disease and malignant hyperpyrexia. Br Med J (1973) 1.17
Etiology and pathophysiology of malignant hyperthermia. Int Anesthesiol Clin (1979) 1.14
The metabolism of arachidonic acid in the isolated tracheal and lung strip preparations of guinea-pigs. Lung (1980) 1.13
Anaphylaxis in guinea-pig peripheral airways in vitro. Eur J Pharmacol (1979) 1.05
Anesthetic-induced malignant hyperpyrexia in children. J Pediatr (1973) 1.04
The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle. Int J Biochem (1993) 0.97
Density gradient studies of A, B, H and Lea blood group specific glycoproteins. Clin Chim Acta (1970) 0.95
The interaction of concanavalin A with blood-group-substance glycoproteins from human secretions. Biochem J (1971) 0.95
A controlled trial of long-term treatment with anticoagulants after myocardial infarction in 412 male patients. Med J Aust (1967) 0.94
Suxamethonium chloride and malignant hyperpyrexia. Br J Anaesth (1986) 0.88
Secretor status in asthma and hay fever. J Med Genet (1968) 0.87
Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine. Lancet (1989) 0.87
Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia. Clin Exp Pharmacol Physiol (1977) 0.87
The ABO system in milk and saliva. Australas Ann Med (1967) 0.86
Molecular cloning of the cDNA encoding human skeletal muscle triadin and its localisation to chromosome 6q22-6q23. Eur J Biochem (1995) 0.84
Effects of anaesthetics on guineapig tracheal smooth muscle. Br J Anaesth (1980) 0.84
A study of the action of caffeine, halothane, potassium chloride and procaine on normal human skeletal muscle. Clin Exp Pharmacol Physiol (1975) 0.83
The effects of chlorbutol on skeletal muscle sarcoplasmic reticulum function in porcine malignant hyperpyrexia. Int J Biochem (1987) 0.82
The pathopharmacology of malignant hyperpyrexia. Pharmacol Ther (1980) 0.82
Screening for malignant hyperpyrexia. Br J Anaesth (1977) 0.81
Calcium currents and asymmetric charge movement in malignant hyperpyrexia. Muscle Nerve (1989) 0.81
Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia. Br J Anaesth (1980) 0.81
Malignant hyperpyrexia in Australia and New Zealand. Med J Aust (1973) 0.80
Identification of susceptibility to malignant hyperpyrexia in swine. Br J Anaesth (1979) 0.80
Serum blood group substances and ABO haemolytic disease. Br J Haematol (1969) 0.79
Drug interactions in cat isolated tracheal smooth muscle. Clin Exp Pharmacol Physiol (1979) 0.79
The effect of histamine on cyclic AMP levels in guinea-pig tracheal smooth muscle. Eur J Pharmacol (1980) 0.79
The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle. Clin Exp Pharmacol Physiol (1991) 0.78
Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine. Br J Anaesth (1981) 0.78
Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle. Br J Anaesth (1989) 0.78
Drug treatment of malignant hyperpyrexia. Anaesth Intensive Care (1977) 0.78
Letter: Myopathies and malignant hyperpyrexia. Br Med J (1974) 0.78
Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia. J Med Genet (1995) 0.78
Smooth muscle contracture in malignant hyperpyrexia. Br J Anaesth (1980) 0.78
Interaction of chlorpromazine with bile. Clin Chem (1971) 0.77
Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle. Clin Exp Pharmacol Physiol (1989) 0.77
The effects of imidazole on contractility and cyclic AMP levels of guinea-pig tracheal smooth muscle. Clin Exp Pharmacol Physiol (1982) 0.77
Detection and partial purification of inositol 1,4,5-trisphosphate 3-kinase from porcine skeletal muscle. Cell Signal (1994) 0.77
Insulin secretion in malignant hyperpyrexia. Br Med J (1974) 0.76
Failure of phenol to remove residual protein from hyaluronic acid. Nature (1965) 0.76
The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle. Eur J Biochem (1994) 0.76
Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle. Arch Biochem Biophys (1994) 0.76
The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs. Biochem J (1983) 0.75
31P-NMR spectroscopy: the metabolic profile of malignant hyperpyrexic porcine skeletal muscle. Muscle Nerve (1989) 0.75
Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism. Biochem Biophys Res Commun (1994) 0.75
Malignant hyperpyrexia. Br Med J (1971) 0.75
Letter: Serum creatin phosphokinase and malignant hyperpyrexia. Br Med J (1975) 0.75
The isolation and chemical characterization of skeletal muscle microsomes from swine susceptible to malignant hyperpyrexia. Int J Biochem (1982) 0.75
Electrophoretic analysis of proteins in malignant hyperpyrexia susceptible skeletal muscle. Int J Biochem (1984) 0.75
Effects of adenylate cyclase activators on porcine skeletal muscle in malignant hyperpyrexia. Br J Anaesth (1987) 0.75
Quantitative estimation of neutral and amino sugars of glycoproteins from human secretions by gas-liquid chromatography. Biochem Med (1974) 0.75
Dantrolene and calcium uptake by the sarcoplasmic reticulum of malignant hyperpyrexia-susceptible pigs. Gen Pharmacol (1984) 0.75
Gastric glycoproteins in chronic peptic ulcer. Aust N Z J Med (1975) 0.75
Calmodulin and malignant hyperpyrexia. Biochem Med (1984) 0.75
Phosphorus-31 nuclear magnetic resonance studies of muscle metabolism in malignant hyperpyrexia. Br J Anaesth (1984) 0.75
Air filtration for asthma. Br Med J (1971) 0.75
Gastric mucus. Aust N Z J Med (1975) 0.75
Contributing authors. Int Anesthesiol Clin (1979) 0.75
Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane. Br J Anaesth (1989) 0.75
Fatal inherited rhabdomyolysis and malignant hyperthermia. Lancet (1994) 0.75
Plant agglutinins and mitosis. Nature (1968) 0.75
Salicylates and gastric juice. J Pharm Pharmacol (1970) 0.75
Characterization of the terminal cisternae and longitudinal tubules of sarcoplasmic reticulum from malignant hyperpyrexia susceptible porcine skeletal muscle. Int J Biochem (1989) 0.75
Malignant hyperpyrexia. Med J Aust (1977) 0.75
Clodanolene sodium and malignant hyperpyrexia. Br J Anaesth (1982) 0.75
Letter: Malignant hypersyrexia or the XX-XY Turner phenotype? J Pediatr (1973) 0.75
Interaction of tricyclic drugs and human bile. Chem Biol Interact (1972) 0.75
Calmodulin-antagonist drugs and porcine malignant hyperpyrexia. Clin Exp Pharmacol Physiol (1988) 0.75
Propofol anaesthesia in malignant hyperpyrexia susceptible swine. Clin Exp Pharmacol Physiol (1992) 0.75
The effect of the calcium ion antagonist 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate on malignant hyperpyrexia-susceptible porcine skeletal muscle. Clin Exp Pharmacol Physiol (1984) 0.75
Calmodulin in porcine malignant hyperpyrexia. Int J Biochem (1987) 0.75
Isolation of glycoproteins from human gastric juice and salive by density gradient ultracentrifugation. Clin Chem (1971) 0.75
Phenothiazines and jaundice. Aust N Z J Med (1972) 0.75
Thiophosphorylation of skeletal muscle sarcoplasmic reticulum in porcine malignant hyperpyrexia. Int J Biochem (1987) 0.75
The effects of calmodulin antagonist drugs on isolated sarcoplasmic reticulum from malignant hyperpyrexia susceptible swine. Int J Biochem (1987) 0.75
Liver dysfunction and hypoxaemia in patients with fractures. Med J Aust (1973) 0.75
A novel method for the isolation of calsequestrin from porcine skeletal muscle sarcoplasmic reticulum. Biochim Biophys Acta (1983) 0.75
Serum intestinal alkaline phosphatase, ABO blood group, secretor status, and lipaemia. Clin Genet (1971) 0.75
Inositol 1,4,5-trisphosphate metabolism in red blood cells from individuals susceptible to malignant hyperpyrexia. Lancet (1993) 0.75
The incidence of anti-A and anti-B isoagglutinins in cord blood and maternal saliva. Br J Haematol (1969) 0.75
The effect of oxytocin on porcine malignant hyperpyrexia susceptible skeletal muscle. Clin Exp Pharmacol Physiol (1987) 0.75
Adenylate kinase and malignant hyperpyrexia. Br J Anaesth (1982) 0.75
Malignant hyperpyrexia. Compr Ther (1975) 0.75
The acute action of urea on ventilatory function in patients with asthma. Med J Aust (1967) 0.75
In vitro action of combined salbutamol and theophylline on anaphylactic contractions, mediator release and cyclic 3',5'-adenosine monophosphate in lung parenchyma. Eur J Pharmacol (1979) 0.75
Comparison of adenylate kinase from normal and malignant hyperpyrexic porcine muscle. Biochem Med (1983) 0.75